3-Hydroxycinnamic acid

CAS No. 14755-02-3

3-Hydroxycinnamic acid( meta-Coumaric acid | m-Coumaric acid | m-Coumarate )

Catalog No. M20834 CAS No. 14755-02-3

3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl . 3-Hydroxycinnamic acid has antioxidant activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 38 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Hydroxycinnamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl . 3-Hydroxycinnamic acid has antioxidant activity.
  • Description
    3-Hydroxycinnamic acid is a natual product isolated from Cinnamomum cassia Presl . 3-Hydroxycinnamic acid has antioxidant activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    meta-Coumaric acid | m-Coumaric acid | m-Coumarate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14755-02-3
  • Formula Weight
    164.16
  • Molecular Formula
    C9H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:32 mg/mL (194.93 mM)
  • SMILES
    O=C(O)/C=C/c1cccc(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chuang JY Tsai YY Chen SCet al. Induction of G0 / G1 arrest and apoptosis by 3-hydroxycinnamic acid in human cervix epithelial carcinoma (HeLa) cells[J]. Vivo 2005 19(4):683-688.
molnova catalog
related products
  • S-I-G-S-L-A-K

    SIGSLAK has the active site of E. coli penicillin-binding protein 1b.

  • Protogracillin

    Protogracillin is a steroidal saponin isolated from Dioscorea zingiberensis Wright (DZW) which may inhibit platelet aggregation (PAG) and thrombosis. Steroidal saponins from DZW rhizomes have the potential to reduce the risk of cardiovascular diseases by anti-thrombotic action.

  • Imaprelimab

    Imaprelimab (PRX-003) is a humanized IgG1 κ monoclonal antibody targeting melanoma cell adhesion molecule (MCAM), with antitumor activity and applications in studying inflammation, tumors, and psoriasis.